A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
Clinical trial NCT01697501 · COMPLETED
Trial details
- NCT number
- NCT01697501
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-08
- Primary completion
- 2013-06-21
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.